HMGB3 is a potential diagnostic marker for early cervical lesion screening

Qianwen Cui; Jiarong Zhao; Qingmei Deng; Yu Liu; Changfang Fu; Qiang Wu; Qiuyan Sun; Haiyan Weng; Haiming Dai; Wulin Yang

doi:10.1016/j.gendis.2023.02.033

您当前的位置：

首页 >

文章列表页 >

HMGB3 is a potential diagnostic marker for early cervical lesion screening

Rapid Communications | 更新时间：2024-02-04

- HMGB3 is a potential diagnostic marker for early cervical lesion screening
- HMGB3 is a potential diagnostic marker for early cervical lesion screening
- Genes & Diseases 2023年1卷第6期页码：2202-2205
- 作者机构：
  
  1. Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences,Anhui,Hefei,China,230031
  2. Science Island Branch, Graduate School of University of Science and Technology of China,Anhui,Hefei,China,230026
  3. Medical Pathology Center, Hefei Cancer Hospital, Chinese Academy of Sciences,Anhui,Hefei,China,230031
  4. The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China,Anhui,Hefei,China,230001
  5. Department of Pathology, The First Affiliated Hospital of Anhui Medical University,Anhui,Hefei,China,230601
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2023.02.033
  中图分类号：
- 纸质出版日期：2023，
  
  网络出版日期：2023-11-1，
扫描看全文
HMGB3 is a potential diagnostic marker for early cervical lesion screening[J]. Genes & Diseases, 2023,1(6):2202-2205.

Qianwen Cui, Jiarong Zhao, Qingmei Deng, et al. HMGB3 is a potential diagnostic marker for early cervical lesion screening[J]. Genes & Diseases, 2023,1(6):2202-2205.
HMGB3 is a potential diagnostic marker for early cervical lesion screening[J]. Genes & Diseases, 2023,1(6):2202-2205. DOI： 10.1016/j.gendis.2023.02.033.

Qianwen Cui, Jiarong Zhao, Qingmei Deng, et al. HMGB3 is a potential diagnostic marker for early cervical lesion screening[J]. Genes & Diseases, 2023,1(6):2202-2205. DOI： 10.1016/j.gendis.2023.02.033.

摘要

Abstract

关键词

Keywords

references

1 M. Zheng, L. Hou, Y. Ma, et al.Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors Mol Cancer, 18 (1) (2019), p. 76

2 W. Chantima, C. Thepthai, P. Cheunsuchon, et al.EpCAM expression in squamous cell carcinoma of the uterine cervix detected by monoclonal antibody to the membrane-proximal part of EpCAM BMC Cancer, 17 (1) (2017), p. 811

3 B. Umphress, B. Sanchez, A. Paintal, et al.Utility of CK7 versus P16 as a prognostic biomarker in CIN 2 Am J Surg Pathol, 42 (4) (2018), pp. 479-484

4 S. Wong, W. Hong, P. Hui, et al.Comprehensive analysis of PAX8 expression in epithelial malignancies of the uterine cervix Int J Gynecol Pathol, 36 (2) (2017), pp. 101-106

5 J. Kaur, P. Dey, S.C. Saha, et al.Cervical cytology in patients with postmenopausal bleeding Diagn Cytopathol, 38 (7) (2010), pp. 496-498

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据